# PEACE III (NCT02194842)

> Phase III Radium 223 mCRPC-PEACE III

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02194842
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
- Conditions: Prostate Cancer
- Interventions: Ra223; Enzalutamide
- Enrollment: 446
- Primary outcome: radiological progression-free survival
- Primary outcome: progression-free survival per Blinded Independent Central Review (PFS1B)

## Commentary we found

- YouTube: 10
- X threads: 8
- Podcasts: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=peace-iii-nct02194842

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02194842", "email": "<work email>"}; the inbox owner confirms by the emailed link.